TSXV - Delayed Quote CAD

NuGen Medical Devices Inc. (NGMD.V)

0.0700

0.0000

(0.00%)

At close: May 16 at 3:58:44 PM EDT

NuGen Announces Release of 2024 Annual Financial Results

Toronto, Ontario--(Newsfile Corp. - April 30, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of 2024 Annual Financial Results. Annual Financial Statements Reflect Commercial Ramp UpThe orders announced previously in 2024 were shipped during the fourth quarter of the year, and the sales were recognized at that time. NuGen had a record year of revenue, .

Newsfile 20 days ago

NGMDF
InsuJet Distribution Expands Across Canada

Toronto, Ontario--(Newsfile Corp. - April 24, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is please to report that distribution of The InsuJet™ will be expanded with increased availability across Canada connecting alongside health professionals."Following its Health Canada approval and our nationwide introduction at World Diabetes Day held on November 14th, 2024, The InsuJet™ devi

Newsfile 26 days ago

NGMDF
NuGen Announces the Appointment of Liang Lin as Chief Executive Officer

Toronto, Ontario--(Newsfile Corp. - January 14, 2025) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the appointment of Mr. Liang Lin as the new Chief Executive Officer of NuGen. Liang is the founder and CEO of Sol-Millennium Medical Group ("SolM"), an organization committed to transforming the medical device sector through innovative approaches and a strong focus on

Newsfile 4 months ago

NGMDF
NuGen Announces Canada-Wide Launch of InsuJet

3,250 InsuJet Starter Packs Being Delivered to Pharmacies Across Canada Toronto, Ontario--(Newsfile Corp. - November 22, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce the national launch of InsuJet™ in Canada. The launch began on November 15, in conjunction with the commemoration of the World Diabetes Day, where InsuJet™ was celebrated and recognized at a spec

Newsfile 5 months ago

NGMDF
NuGen Announces Results of Special Meeting and Appointment of New Directors

Toronto, Ontario--(Newsfile Corp. - November 14, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that its shareholders have approved Sol-Millennium Medical HK Limited ("Sol-M") and Nature Health Development (Hong Kong) Co. Limited ("Nature Health") as new Control Persons (as defined in the policies of the TSX Venture Exchange) of the Company. On September 20, 20

Newsfile 6 months ago

NGMDF
NuGen Announces Strategic Partnership with EziAutoJector Limited

5,000 InsuJet devices to be delivered to the UK Toronto, Ontario--(Newsfile Corp. - October 25, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce a strategic partnership with EziAutoJector® Limited ("EziAutoJector"), a company domiciled in Jersey, United Kingdom, for the delivery of U-100 insulin to individuals with diabetes and subcutaneous biosimilar products us

Newsfile 6 months ago

NGMDF
NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures

Toronto, Ontario--(Newsfile Corp. - September 20, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that, further to its press release dated August 15, 2024, Sol-Millennium Medical HK Limited ("Sol-M") and Nature Health Development (Hong Kong) Co. Limited ("Nature Health") have completed their strategic investment in NuGen through the acquisition of an aggregate C

Newsfile 7 months ago

NGMDF
NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement

Toronto, Ontario--(Newsfile Corp. - August 29, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, announces the release of Q2 2024 Financial Results and is pleased to provide updates on commercial progress and its proposed private placement of up to $10 million secured convertible debentures (the "Offering"). Q2 Financial Statements Reflect Continued Commercial Ramp-UpFinancial

Newsfile 8 months ago

NGMDF
NuGen Announces Voting Results of Annual and Special Meeting

Toronto, Ontario--(Newsfile Corp. - August 21, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce voting results from the annual and special meeting of the Company's shareholders (the "Meeting") held on August 20, 2024. At the Meeting, shareholders voted in favour of all resolutions brought before them. Details of all resolutions that were voted upon are set ...

Newsfile 8 months ago

NGMDF
NuGen Announces Revised Terms of Proposed Private Placement of up to $10 Million Secured Convertible Debentures

Toronto, Ontario--(Newsfile Corp. - August 15, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, announces that price protection has expired for its proposed non-brokered private placement (the "Offering") of up to $10,000,000 principal amount secured convertible debentures (the "Convertible Debentures") announced on July 10, 2024. As such, the Company has revised the terms of the Offer

Newsfile 8 months ago

NGMDF
NuGen Receives Order for Repeat Demand in Mexico

Toronto, Ontario--(Newsfile Corp. - July 19, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that Science Link, the exclusive distributor of the InsujetTM in Mexico has placed an additional order for 4,500 Insujet injectors to support channel expansion and demand growth in the Mexico market. The revenue associated with the order is $525K, contributing an ...

Newsfile 9 months ago

NGMDF
NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures

Toronto, Ontario--(Newsfile Corp. - July 10, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce its intention to complete a non-brokered private placement (the "Offering") of up to $10,000,000 principal amount secured convertible debentures (the "Convertible Debentures"). The Convertible Debentures shall mature on the date that is five (5) years from the closing of

Newsfile 10 months ago

NGMDF
NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market

Toronto, Ontario--(Newsfile Corp. - July 9, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that it has formed a three-way partnership with Wholehealth Pharmacy Partners ("Wholehealth") and Sol-Millennium Medical Group ("Sol-M") to develop retail pharmacy training materials aimed at enhancing sales through major pharmacy chains in Canada.Training pharmacy staff

Newsfile 10 months ago

NGMDF
NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil

Toronto, Ontario--(Newsfile Corp. - July 1, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that as of June 26, 2024, the commercial teams of Sol-MillenniumTM Medical Inc. ("Sol-MTM") in Brazil have successfully completed the sales and in-depth clinical training required for InsuJetTM's launch in the Brazilian market. This is the next step in the rollout ...

Newsfile 10 months ago

NGMDF
NuGen Announces Repeat Order for Growing InsuJet(TM) Demand in Yemen

Toronto, Ontario--(Newsfile Corp. - June 28, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, is pleased to announce that Rosheta for Medicines and Medical Supplies ("Rosheta"), NuGen's exclusive distributor in Yemen, has placed a second order to fulfill growing demand in the country.The order includes 1,100 InsuJetTM units and associated consumables representing revenue of $147,000, a

Newsfile 10 months ago

NGMDF
NuGen Announces Initial Purchase Order from Sol-Millennium(TM) for Pharmacy Launches in the Canadian and European Markets

Toronto, Ontario--(Newsfile Corp. - June 21, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices for the subcutaneous administration of therapeutics, is pleased to announce that Sol-MillenniumTM Medical Inc. ("Sol-M") has placed its initial purchase order of 3,832 InsuJetTM injectors plus consumables to fulfill the first pharmacy orders received by Sol-M from distributors in Canada and Switzerland. NuGen is expected to deliver the

Newsfile 10 months ago

NGMDF
NuGen Announces Release of Financial Results for Q1 2024 & Updates on Strong Commercial Momentum in Q2

Toronto, Ontario--(Newsfile Corp. - May 30, 2024) - NuGen Medical Devices Inc. (TSXV: NGMD) (the "Company" or "NuGen") a leading developer of needle-free devices to administer therapeutics subcutaneously, announces the release Q1 2024 Financial Results and is pleased to provide an update on the strong commercial progress made year to date. Q1 Financials in Line with Management ExpectationsFinancial Results for the Q1 period were in line with management expectations. It was a period focused ...

Newsfile 11 months ago

NGMDF

Performance Overview

Return	NGMD.V	S&P/TSX Composite index (^GSPTSE)
YTD	-6.67%	+5.83%
1-Year	-30.00%	+15.98%
3-Year	-63.16%	+29.00%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

NuGen Medical Devices Inc. (NGMD.V)

NuGen Announces Release of 2024 Annual Financial Results

InsuJet Distribution Expands Across Canada

NuGen Announces the Appointment of Liang Lin as Chief Executive Officer

NuGen Announces Canada-Wide Launch of InsuJet

NuGen Announces Results of Special Meeting and Appointment of New Directors

NuGen Announces Strategic Partnership with EziAutoJector Limited

NuGen Announces Closing of Private Placement of $10 million Secured Convertible Debentures

NuGen Announces Release of Financial Results for Q2 2024 & Update on Proposed Private Placement

NuGen Announces Voting Results of Annual and Special Meeting

NuGen Announces Revised Terms of Proposed Private Placement of up to $10 Million Secured Convertible Debentures

NuGen Receives Order for Repeat Demand in Mexico

NuGen Announces Proposed Private Placement of up to $10 million Secured Convertible Debentures

NuGen Develops Pharmacist Training Packages for the Canadian Retail Pharmacy Market

NuGen Announces Completion of InsuJet(TM) Training with Sol-Millennium(TM) Brazil

NuGen Announces Repeat Order for Growing InsuJet(TM) Demand in Yemen

NuGen Announces Initial Purchase Order from Sol-Millennium(TM) for Pharmacy Launches in the Canadian and European Markets

NuGen Announces Release of Financial Results for Q1 2024 & Updates on Strong Commercial Momentum in Q2

Performance Overview